# Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of  of HIV-1 and HCV:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-on-pooled-and-individual-samples-from-donors-of-whole-blood-and-blood-components-including-source-plasma-and-source-leukocytes-to-adequately-and-appropriately-reduce-the-risk-of-transmission-of-of-hiv-1-and-hcv-guidance-for-industry/0f8804f2-4963-49e6-81ca-6607c2f954aa

> FDA guidance document: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of  of HIV-1 and HCV:  Guidance for Industry. Issue date: October 21, 2004. Get complete insights and analysis.

---

## Details

- Title: Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components (including Source Plasma and Source Leukocytes) to Adequately and Appropriately Reduce the Risk of Transmission of  of HIV-1 and HCV:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research
- Office URL: /offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
- Issue Date: 2004-10-21
- Last Changed: 2024-05-08
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0095">FDA-2001-D-0095</a>

## Related Documents

- [Use of Nucleic Acid Tests to Reduce the Risk of Transmission of West Nile Virus from Donors of Whole Blood and Blood Components Intended for Transfusion:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-to-reduce-the-risk-of-transmission-of-west-nile-virus-from-donors-of-whole-blood-and-blood-components-intended-for-transfusion-guidance-for-industry/863d535f-7224-46e2-84c2-785caa4abcf3)
- [Adequate and Appropriate Donor Screening Tests for Hepatitis B; Hepatitis B Surface Antigen (HBsAg) Assays Used to Test Donors of Whole Blood and Blood Components, Including Source Plasma and Source Leukocytes:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/adequate-and-appropriate-donor-screening-tests-for-hepatitis-b-hepatitis-b-surface-antigen-hbsag-assays-used-to-test-donors-of-whole-blood-and-blood-components-including-source-plasma-and-source-leukocytes-guidance-for-industry/6e1a3dc6-02e1-498b-91e1-0f50f5544d60)
- [Use of Nucleic Acid Tests on Pooled and Individual Samples From Donors of Whole Blood and Blood Components, Including Source Plasma, to Reduce the Risk of Transmission of Hepatitis B Virus:  Final Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/use-of-nucleic-acid-tests-on-pooled-and-individual-samples-from-donors-of-whole-blood-and-blood-components-including-source-plasma-to-reduce-the-risk-of-transmission-of-hepatitis-b-virus-final-guidance-for-industry/e8fb757d-ba0b-4dd1-9173-494e61da9b48)